The limited efficacy of methotrexate, actinomycin D and cisplatin (MAP) for patients with advanced testicular cancer

Japanese Journal of Clinical Oncology

Volumn 33, Issue 8, 2003, Pages 391-395

  Miyazaki, Jun ^a   Kawai, Koji ^a   Hayashi, Hitoshi ^a   Onozawa, Mizuki ^a   Tsukamoto, Sadamu ^a   Miyanaga, Naoto ^a   Hinotsu, Shiro ^a   Shimazui, Toru ^a   Akaza, Hideyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Actinomycin; Cisplatin; Methorexate; Testicular cancer

Indexed keywords

ANTIBIOTIC AGENT; BLEOMYCIN; CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; METHOTREXATE; PACLITAXEL; VINBLASTINE;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ADVANCED CANCER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RELAPSE; CHORIOCARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FEBRILE NEUTROPENIA; GONADOTROPIN BLOOD LEVEL; HUMAN; LEUKOPENIA; MALE; MALE GENITAL SYSTEM SURGERY; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; SALVAGE THERAPY; TESTIS CANCER; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT FAILURE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHORIOCARCINOMA; CISPLATIN; DACTINOMYCIN; DRUG ADMINISTRATION SCHEDULE; HUMANS; LEUKOPENIA; MALE; METHOTREXATE; MIDDLE AGED; SALVAGE THERAPY; TESTICULAR NEOPLASMS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 30844463229     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg074     Document Type: Article

References (17)

1. Williams SD, Birch R, Einhorn LH, Erwin L, Greco FA, Loehrer PJ. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 1987;316:1435-40.
2. McCaffrey JA, Mazumdar M, Bajorin DF, Bosl GJ, Vlamis V, Motzer RJ. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: Response and survival. J Clin Oncol 1997;15: 2559-63.
3. Loehrer PJ Sr, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH. Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 1988;109:540-6.
4. Lurain JR. High-risk metastatic gestational trophoblastic tumors. Current management. J Reprod Med 1994;39:217-22.
5. Kendall A, Gillmore R, Newlands E. Chemotherapy for trophoblastic disease: Current standards. Curr Opin Obstet Gynecol 2002;14:33-8.
6. Levi JA, Thomson D, Harvey V, Gill G, Raghavan D, Tattersall M, et al. Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group. J Clin Oncol 1990;8:27-32.
7. Sleijfer S, Van der Graaf WT, Willemse PH, De Vries EG, Schraffordt Koops H, Mulder NH. High-dose methotrexate, vincristine and cisplatin as salvage treatment for relapsed non-seminomatous germ-cell cancer. Anticancer Res 1995;15:1039-42.
8. Japanese Urological Association and Japanese Pathological Society. General Rules for Clinical and Pathological Studies on Testicular Tumors, 2nd ed. Tokyo: Kanehara 1997.
9. Arbuck S, McClure J, Ivy S, Setser A. The Common Toxicity Criteria: Version 2.0 CTEP Website, http://ctep.info.nih.gov, 1999.
10. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997;15:594-603.
11. Berkowitz RS, Goldstein DP. Gestational trophoblastic disease. Cancer 1995;76:2079-85.
12. Newlands ES, Bagshawe KD, Begent RH, Rustin GJ, Crawford SM, Holden L. Current optimum management of anaplastic germ cell tumours of the testis and other sites. Br J Urol 1986;58:307-14.
13. Atkinson CH, Horwich A, Peckham MJ. Methotrexate for relapse of metastatic non-seminomatous germ-cell tumours. Med Oncol Tumor Pharmacother 1987;4:33-7.
14. Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, et al. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res 1992;52:3901-7.
15. Hoshi S, Suzuki K, Ishidoya S, Ohyama C, Sato M, Namima T, et al. Significance of simultaneous determination of serum human chorionic gonadotropin (hCG) and hCG-beta in testicular tumor patients. Int J Urol 2000;7:218-23.
16. Hinton S, Catalano P, Einhorn LH, Loehrer PJ Sr, Kuzel T, Vaughn D, et al. Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2002;20:1859-63.
17. Kollmannsberger C, Rick O, Klaproth H, Kubin T, Sayer HG, Hentrich M, et al. Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: A phase II study of the German Testicular Cancer Study Group. Br J Cancer 2002;87:729-32.